{"id":665921,"date":"2025-12-12T13:07:03","date_gmt":"2025-12-12T13:07:03","guid":{"rendered":"https:\/\/microscopemedia.com\/?p=665921"},"modified":"2025-12-12T13:07:03","modified_gmt":"2025-12-12T13:07:03","slug":"noul-medicament-pentru-obezitatea-la-pisici-un-implant-ar-putea-deveni-alternativa-veterinara-la-ozempic","status":"publish","type":"post","link":"https:\/\/microscopemedia.com\/?p=665921","title":{"rendered":"Noul medicament pentru obezitatea la pisici. Un implant ar putea deveni alternativa veterinar\u0103 la Ozempic"},"content":{"rendered":"<div><img decoding=\"async\" src=\"https:\/\/microscopemedia.com\/wp-content\/uploads\/2025\/12\/noul-medicament-pentru-obezitatea-la-pisici-un-implant-ar-putea-deveni-alternativa-veterinara-la-ozempic.jpg\" class=\"ff-og-image-inserted\"><\/div>\n<p data-start=\"227\" data-end=\"622\" id=\"p-0\">Compania farmaceutic\u0103 veterinar\u0103 OKAVA Pharmaceuticals a anun\u021bat lansarea primului s\u0103u studiu clinic pentru testarea implantului OKV-119, un sistem ce administreaz\u0103 lent o substan\u021b\u0103 cu efecte similare medicamentelor Ozempic \u0219i Wegovy utilizate \u00een medicina uman\u0103. scrie <a href=\"https:\/\/www.sciencealert.com\/ozempic-for-cats-is-coming-and-vets-are-testing-it-on-overweight-pets\" target=\"_blank\" rel=\"noopener\">Science Alert<\/a>.<\/p>\n<h2 data-start=\"624\" data-end=\"698\" id=\"chapter-0\">Testat \u00een premier\u0103<\/h2>\n<p data-start=\"700\" data-end=\"1039\" id=\"p-1\">Potrivit companiei, OKV-119 este un agonist al receptorilor GLP-1, o categorie de medicamente ce imit\u0103 hormonii naturali ai sa\u021biet\u0103\u021bii \u0219i regleaz\u0103 glicemia. Receptorii GLP-1 sunt foarte bine conserva\u021bi la mamifere, ceea ce a permis dezvoltarea unui medicament pentru obezitatea la pisici cu poten\u021bial similar celor destinate oamenilor.<\/p>\n<p data-start=\"1041\" data-end=\"1285\" id=\"p-2\">Implantul se administreaz\u0103 sub piele \u0219i elibereaz\u0103 treptat substan\u021ba activ\u0103 timp de aproximativ \u0219ase luni, o alternativ\u0103 mult mai u\u0219or de acceptat pentru proprietarii de animale care \u00eent\u00e2mpin\u0103 dificult\u0103\u021bi \u00een administrarea tratamentelor zilnice.<\/p>\n<h2 data-start=\"1287\" data-end=\"1380\" id=\"chapter-1\">Cum func\u021bioneaz\u0103 \u0219i de ce ar putea fi eficient<\/h2>\n<p data-start=\"1382\" data-end=\"1830\" id=\"p-3\">CEO-ul OKAVA, Michael Klotsman, explic\u0103 faptul c\u0103 OKV-119 este proiectat s\u0103 reproduc\u0103 efectele fiziologice ale postului: cre\u0219terea sensibilit\u0103\u021bii la insulin\u0103, reducerea masei adipoase \u0219i optimizarea metabolismului energetic. Acest tip de medicament&nbsp;ar putea facilita pierderea \u00een greutate f\u0103r\u0103 modific\u0103ri drastice ale rutinei de hr\u0103nire, un aspect important pentru animalele ata\u0219ate de ritualurile legate de m\u00e2ncare.<\/p>\n<p data-start=\"1832\" data-end=\"2184\" id=\"p-4\">\u00cen prezent, doar o singur\u0103 pisic\u0103 a primit implantul \u00een cadrul studiului clinic, ceea ce \u00eenseamn\u0103 c\u0103 eficacitatea tratamentului \u00eenc\u0103 nu este demonstrat\u0103. Totu\u0219i, testele anterioare au ar\u0103tat c\u0103 sistemul este sigur pentru animalele s\u0103n\u0103toase, iar noul studiu clinic de 12 s\u0103pt\u0103m\u00e2ni \u00ee\u0219i propune s\u0103 stabileasc\u0103 efectele implantului asupra pisicilor obeze.<\/p>\n<h2 data-start=\"2186\" data-end=\"2248\" id=\"chapter-2\">Recomand\u0103ri actuale pentru gestionarea greut\u0103\u021bii la pisici<\/h2>\n<p data-start=\"2250\" data-end=\"2688\" id=\"p-5\">P\u00e2n\u0103 la apari\u021bia unor rezultate clare privind noul medicament pentru obezitatea la pisici, speciali\u0219tii recomand\u0103 reducerea accesului permanent la hran\u0103 \u0219i utilizarea juc\u0103riilor de tip puzzle pentru stimularea comportamentului natural de v\u00e2n\u0103toare.<\/p>\n<p data-start=\"2250\" data-end=\"2688\" id=\"p-6\">Felinele supraponderale au risc crescut de osteoartrit\u0103, diabet, probleme cardiovasculare \u0219i complica\u021bii hepatice, ceea ce face controlul greut\u0103\u021bii esen\u021bial pentru men\u021binerea s\u0103n\u0103t\u0103\u021bii.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Compania farmaceutic\u0103 veterinar\u0103 OKAVA Pharmaceuticals a anun\u021bat lansarea primului s\u0103u studiu clinic pentru testarea implantului OKV-119, un sistem ce administreaz\u0103 lent o substan\u021b\u0103 cu efecte similare medicamentelor Ozempic \u0219i Wegovy &hellip; <a href=\"https:\/\/microscopemedia.com\/?p=665921\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":665922,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/665921"}],"collection":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=665921"}],"version-history":[{"count":0,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/665921\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/media\/665922"}],"wp:attachment":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=665921"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=665921"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=665921"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}